INmune Bio, Inc. (INMB)
NASDAQ: INMB · Real-Time Price · USD
7.93
+0.66 (9.08%)
Jun 4, 2025, 1:55 PM - Market open
INmune Bio Market Cap
INmune Bio has a market cap or net worth of $184.06 million as of June 4, 2025. Its market cap has decreased by -16.70% in one year.
Market Cap
184.06M
Enterprise Value
154.62M
1-Year Change
-16.70%
Ranking
Category
Stock Price
$7.93
Market Cap Chart
Since February 4, 2019, INmune Bio's market cap has increased from $77.82M to $184.06M, an increase of 136.50%. That is a compound annual growth rate of 14.56%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.23B |
| Johnson & Johnson | 373.45B |
| AbbVie | 328.75B |
| Novo Nordisk | 305.07B |
| UnitedHealth Group | 273.87B |
| Abbott Laboratories | 232.41B |
| AstraZeneca | 224.00B |
| Novartis AG | 223.92B |